Talphera (TLPH) EBIT (2010 - 2026)
Talphera (TLPH) posted EBIT of -$3.9 million for Q2 2026, up 0.61% on a QoQ basis from -$3.9 million in Q1 2026, and down 6.26% year-over-year from -$4.2 million in Q2 2025.
Analysis
Talphera (TLPH) EBIT (2010 - 2026) Analysis & Trends
Talphera has reported EBIT for 17 years, with the latest figure at -$3.9 million in Q2 2026.
- On a quarterly basis, EBIT fell 6.26% year-over-year to -$3.9 million in Q2 2026; TTM through Jun 2026 was -$14.7 million, a 10.43% decrease from a year earlier, with the FY2025 full-year figure at -$13.5 million, up 11.59% from the prior year.
- EBIT was -$3.9 million for Q2 2026 at Talphera, up from -$3.9 million in the prior quarter.
- The five-year high for EBIT was $3.9 million in Q4 2022, with the low at -$13.6 million in Q2 2022.
- Average EBIT over 5 years is -$4.3 million, with a median of -$3.9 million recorded in 2026.
- The sharpest annual moves came in 2022 and 2023: EBIT jumped 147.71% in 2022, then tumbled 209.82% in 2023.
- Over 5 years, EBIT stood at $3.9 million in 2022, then sank by 209.82% to -$4.3 million in 2023, then soared by 30.05% to -$3.0 million in 2024, then slipped by 15.25% to -$3.5 million in 2025, then declined by 13.64% to -$3.9 million in 2026.
- The last three EBIT figures came in at -$3.9 million (Q2 2026), -$3.9 million (Q1 2026), and -$3.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.69 Bn | 192.70 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 179.87 Bn | 176.70 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.70 Bn | 73.71 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 54.28 Bn | 49.14 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.02 Bn | 29.71 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | -365.99 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | -3.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.92 Mn |
| Mar 31, 2026 | -3.95 Mn |
| Dec 31, 2025 | -3.45 Mn |
| Sep 30, 2025 | -3.42 Mn |
| Jun 30, 2025 | -3.69 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Sep 30, 2024 | -3.75 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Dec 31, 2023 | -4.28 Mn |
| Sep 30, 2023 | -3.31 Mn |
| Jun 30, 2023 | -3.97 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -13.57 Mn |
| Mar 31, 2022 | -9.00 Mn |
| Dec 31, 2021 | -8.18 Mn |
| Sep 30, 2021 | -8.63 Mn |
| Jun 30, 2021 | -10.02 Mn |